Your browser doesn't support javascript.
loading
Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial.
Hildesheim, Allan; Wacholder, Sholom; Catteau, Gregory; Struyf, Frank; Dubin, Gary; Herrero, Rolando.
Afiliação
  • Hildesheim A; National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics, 9609 Medical Center Drive, Bethesda, MD 20892, United States. Electronic address: hildesha@exchange.nih.gov.
  • Wacholder S; National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics, 9609 Medical Center Drive, Bethesda, MD 20892, United States. Electronic address: wacholds@exchange.nih.gov.
  • Catteau G; GlaxoSmithKline Vaccines, Avenue Fleming 20, B-1300 Wavre, Belgium. Electronic address: gregory.x.catteau@gsk.com.
  • Struyf F; GlaxoSmithKline Vaccines, Avenue Fleming 20, B-1300 Wavre, Belgium. Electronic address: frank.struyf@gsk.com.
  • Dubin G; GlaxoSmithKline SA, 2301 Renaissance 22 Boulevard, RN0220, King of Prussia, PA 19406, United States. Electronic address: Gary.O.Dubin@gsk.com.
  • Herrero R; Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Solarium Bldg., Liberia, Costa Rica. Electronic address: HerreroR@iarc.fr.
Vaccine ; 32(39): 5087-97, 2014 Sep 03.
Article em En | MEDLINE | ID: mdl-25018097

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Idioma: En Ano de publicação: 2014 Tipo de documento: Article